Great to see our CEO Abraham (Abe) Ceesay featured in the just-released, annual MassBio Industry Snapshot. The report highlights growth across the Massachusetts #lifesciences sector, and Abe shares an update on Rapport’s progress and commitment to advancing precision #neuromedicine for patients living with #CNS disorders.
Did you know that Massachusetts added nearly 3,000 biopharma jobs in 2023? Were you aware that $28.9 billion was spent acquiring Massachusetts biotechs in just the first six months of this year? Did you know that Massachusetts has a higher percentage of advanced modalities in its drug pipeline than any direct competitor? Discover the latest data on the Commonwealth’s #lifesciences industry and hear from leading industry stakeholders in this year’s Industry Snapshot: https://lnkd.in/e8Wdfkzy. #MassBioIndustrySnapshot #biopharma #lifesciences #patientdriven